BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31733651)

  • 1. Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study.
    Garofolo M; Gualdani E; Giannarelli R; Aragona M; Campi F; Lucchesi D; Daniele G; Miccoli R; Francesconi P; Del Prato S; Penno G
    Cardiovasc Diabetol; 2019 Nov; 18(1):159. PubMed ID: 31733651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Witte DR; Jørgensen ME
    Diabetologia; 2019 Apr; 62(4):633-643. PubMed ID: 30649599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2021 Jul; 20(1):133. PubMed ID: 34229668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
    Welsh P; Rankin N; Li Q; Mark PB; Würtz P; Ala-Korpela M; Marre M; Poulter N; Hamet P; Chalmers J; Woodward M; Sattar N
    Diabetologia; 2018 Jul; 61(7):1581-1591. PubMed ID: 29728717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cause-specific mortality rates in patients with diabetes according to comorbid macro- and microvascular complications: BioBank Japan Cohort.
    Yokomichi H; Nagai A; Hirata M; Mochizuki M; Kojima R; Yamagata Z;
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00181. PubMed ID: 33532618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Klein BE; Moss SE; Wong TY
    Ophthalmology; 2007 Oct; 114(10):1884-92. PubMed ID: 17540447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.
    O'Brien R; Johnson E; Haneuse S; Coleman KJ; O'Connor PJ; Fisher DP; Sidney S; Bogart A; Theis MK; Anau J; Schroeder EB; Arterburn D
    Ann Intern Med; 2018 Sep; 169(5):300-310. PubMed ID: 30083761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthostatic hypotension in diabetic patients-10-year follow-up study.
    Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
    J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
    Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
    Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.
    Mohammedi K; Potier L; Belhatem N; Matallah N; Hadjadj S; Roussel R; Marre M; Velho G
    Cardiovasc Diabetol; 2016 Jan; 15():5. PubMed ID: 26743116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
    Hjortebjerg R; Tarnow L; Jorsal A; Parving HH; Rossing P; Bjerre M; Frystyk J
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3032-40. PubMed ID: 26046968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial.
    Díaz-López A; Babio N; Martínez-González MA; Corella D; Amor AJ; Fitó M; Estruch R; Arós F; Gómez-Gracia E; Fiol M; Lapetra J; Serra-Majem L; Basora J; Basterra-Gortari FJ; Zanon-Moreno V; Muñoz MÁ; Salas-Salvadó J;
    Diabetes Care; 2015 Nov; 38(11):2134-41. PubMed ID: 26370380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Astrup AS; Tarnow L; Rossing P; Hansen BV; Hilsted J; Parving HH
    Diabetes Care; 2006 Feb; 29(2):334-9. PubMed ID: 16443883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.